회사의 펀더멘털은 비교적 아주 건전한한 편입니다. 회사의 밸류에이션은 적정하게 평가된으로 간주됩니다. 기관의 인지도는 매우 높은입니다. 지난 30일 동안 여러 애널리스트들이 이 회사를 매수로 평가했습니다. 회사는 주식시장에서 양호한 성과를 보이고 있으며, 견조한 펀더멘털과 기술적 지표가 현재의 추세를 뒷받침하고 있습니다. 주가는 지지선과 저항선 사이에서 횡보하고 있으며, 범위 매매 기반의 스윙 트레이딩에 적합한 상황입니다.
Mckesson Corp 점수
관련 정보
산업 순위
11 / 159
전체 순위
35 / 4608
산업
제약
저항선 & 지지선
데이터 없음
레이더 차트
현재 가격
과거
분석가 목표가
18
명의 분석가를 기준으로
매수
현재 등급
916.149
목표 가격
+6.61%
상승 여력
면책 조항: 애널리스트 평가 및 목표 주가는 정보 제공을 위한 목적으로 LSEG에서 제공되며, 투자 조언으로 간주되지 않습니다.
Mckesson Corp 주요 내용
강점위험 요소
McKesson Corporation is a provider of diversified healthcare services. It is engaged in advancing health outcomes for patients everywhere. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over the counter (OTC) pharmaceutical drugs and other healthcare-related products in the United States. Its Prescription Technology Solutions segment helps solve medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Its Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home healthcare agencies. Its International segment includes its operations in Norway, which provides distribution and services to wholesale and retail customers.
업계 리더
회사의 매출은 업계 선두를 달리고 있으며, 최근 연간 매출은 총 미화 359.05B에 달합니다.
높은 성장
회사의 매출은 지난 3년간 꾸준히 성장해왔으며, 연평균 29.76%의 증가율을 기록했습니다.
McKesson Corporation is a provider of diversified healthcare services. It is engaged in advancing health outcomes for patients everywhere. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over the counter (OTC) pharmaceutical drugs and other healthcare-related products in the United States. Its Prescription Technology Solutions segment helps solve medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Its Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home healthcare agencies. Its International segment includes its operations in Norway, which provides distribution and services to wholesale and retail customers.